QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors

AIM(S): Ciprofloxacin and fluconazole combination therapy is frequently used as prophylaxis for, and treatment of, infections in patients with haematological malignancies. However, both drugs are known to prolong the heart rate‐corrected QT (QTc) interval, which is a serious risk factor for torsade...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Br J Clin Pharmacol
मुख्य लेखकों: Berger, Florine A., Monadian, Nico, de Groot, Natasja M. S., Santbergen, Bart, van der Sijs, Heleen, Becker, Matthijs L., Broers, Annoek E. C., van Gelder, Teun, van den Bemt, Patricia M. L. A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2017
विषय:
Drug Safety
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777440/
https://ncbi.nlm.nih.gov/pubmed/29057492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13457
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन